|
Market Closed -
Japan Exchange
09:30:00 05/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 580.00 JPY | -3.65% |
|
+0.17% | - |
| 08-22 | Certain Common Stock of Innovacell Inc. are subject to a Lock-Up Agreement Ending on 22-AUG-2026. | CI |
| 08-06 | Innovacell Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 26.19B 166M 148M 138M 125M 236M 15.96B 238M 1.66B 648M 8.15B 622M 609M | P/E 2026 * |
-7.12x | P/E 2027 * | -6.71x |
|---|---|---|---|---|---|
| Enterprise Value | 26.19B 166M 148M 138M 125M 236M 15.96B 238M 1.66B 648M 8.15B 622M 609M | EV / Sales 2026 * |
26.2x | EV / Sales 2027 * | 24.3x |
| Free-Float |
51.11% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -3.65% | ||
| 1 week | +0.17% | ||
| Current month | -8.23% | ||
| 1 month | +1.93% | ||
| 3 months | +6.81% | ||
| 6 months | -28.40% |
| 1 week | 572 |  | 643 |
| 1 month | 519 | | 643 |
| Current year | 377 | | 1,248 |
| 1 year | 377 | | 1,248 |
| 3 years | 377 | | 1,248 |
| 5 years | 377 | | 1,248 |
| 10 years | 377 | | 1,248 |
| Manager | Title | Age | Since |
|---|---|---|---|
Colin Lee Novick
CEO | Chief Executive Officer | 45 | 01/03/2022 |
Jason Sieger
CEO | Chief Executive Officer | 44 | 01/03/2025 |
Yasushi Hosono
DFI | Director of Finance/CFO | 59 | 01/07/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Jason Sieger
BRD | Director/Board Member | 44 | 01/01/2021 |
Colin Lee Novick
BRD | Director/Board Member | 45 | 01/07/2021 |
| Director/Board Member | 57 | 01/04/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.65% | +0.17% | - | - | 172M | |
| +0.02% | -3.52% | +35.27% | +111.11% | 1,019B | |
| -1.21% | -6.99% | +34.42% | +60.96% | 617B | |
| +1.12% | -0.20% | +15.45% | +80.24% | 464B | |
| -3.30% | -6.15% | +57.14% | +34.69% | 356B | |
| +0.93% | -3.16% | +21.65% | +43.02% | 333B | |
| +0.12% | -2.77% | +10.70% | +32.97% | 267B | |
| -0.89% | -6.28% | -7.00% | +8.01% | 244B | |
| -0.01% | -3.62% | +37.01% | +52.02% | 218B | |
| -0.08% | -4.98% | +27.34% | +93.61% | 179B | |
| Average | -1.06% | -2.79% | +25.78% | +57.40% | 369.74B | |
| Weighted average by Cap. | -0.54% | -3.54% | +28.68% | +68.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1B 6.33M 5.65M 5.26M 4.79M 9.02M 610M 9.08M 63.56M 24.73M 311M 23.76M 23.25M | 1.08B 6.82M 6.09M 5.67M 5.16M 9.72M 657M 9.79M 68.52M 26.66M 335M 25.61M 25.06M |
| Net income | -3.46B -21.92M -19.55M -18.22M -16.58M -31.22M -2.11B -31.45M -220M -85.64M -1.08B -82.28M -80.51M | -3.81B -24.1M -21.5M -20.03M -18.23M -34.33M -2.32B -34.58M -242M -94.17M -1.18B -90.48M -88.53M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/10/26 | ¥580.00 | -3.65% | 68,900 |
| 02/10/26 | ¥602.00 | -3.06% | 96,000 |
| 01/10/26 | ¥621.00 | -1.74% | 96,500 |
| 30/09/26 | ¥632.00 | +4.98% | 126,900 |
| 29/09/26 | ¥602.00 | +1.01% | 79,200 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 504A Stock
Select your edition
All financial news and data tailored to specific country editions
